Methods for detection and quantification of analytes in complex mixtures
Abstract
The invention provides a diverse population of uniquely labeled probes, containing about thirty or more target specific nucleic acid probes each attached to a unique label bound to a nucleic acid. Also provided is a method of producing a population of uniquely labeled nucleic acid probes. The method consists of (a) synthesizing a population of target specific nucleic acid probes each having a different specifier; (b) synthesizing a corresponding population of anti-genedigits each having a unique label, the population having a diversity sufficient to uniquely hybridize to genedigits within the specifiers, and (c) hybridizing the populations of target nucleic acid probes to the anti-genedigits, to produce a population in which each of the target specific probes is uniquely labeled. Also provided is a method of detecting a nucleic acid analyte. The method consists of (a) contacting a mixture of nucleic acid analytes under conditions sufficient for hybridization with a plurality of target specific nucleic acid probes each having a different specifier; (b) contacting the mixture under conditions sufficient for hybridization with a corresponding plurality of anti-genedigits each having a unique label, the plurality of anti-genedigits having a diversity sufficient to uniquely hybridize to genedigits within the specifiers, and (c) uniquely detecting a hybridized complex between one or more analytes in the mixture, a target specific probe, and an anti-genedigit.
Claims
exact text as granted — not AI-modified1 .- 15 . (canceled)
16 . A method of producing a population of labels, comprising synthesizing a population of nucleic acids, each of said nucleic acids within said synthesized population having bound a predetermined ratio of at least two different label monomers, wherein said population of labels has a diversity of predetermined ratios of about 30 or more.
17 . The method of claim 16 , wherein each of said nucleic acids bound by a predetermined ratio of at least two labels further comprises about the same unit signal.
18 . The method of claim 16 , wherein said diversity is selected from the group consisting of 40, 60, 80, 100, 120, 140, and 150.
19 . The method of claim 16 , wherein said diversity is selected from the group consisting of 200, 500, 2,000, 5,000, 1×10 4 , 3×10 4 and 1×10 5 .
20 . The method of claim 16 , wherein said labels are fluorescent.
21 . The method of claim 16 , wherein each of said nucleic acids within said synthesized population further comprise an anti-genedigit.
22 . The method of claim 16 , wherein each of said nucleic acids within said synthesized population further comprise a target specific probe.
23 .- 33 . (canceled)
34 . A method of producing a target specific nucleic acid probe, comprising: (a) producing a first nucleic acid comprising a target specific probe, wherein said target specific probe comprises a target specific region and a region comprising a plurality of genedigits linked together in a unique combination, each genedigit being of predetermined nucleotide sequence, wherein at least two of said genedigits have different nucleotide sequences; (b) producing a second nucleic acid comprising two or more different anti-genedigits, wherein each anti-genedigit hybridizes to a genedigit in said target specific probe, and (c) hybridizing said first and second nucleic acids to produce a target specific nucleic acid probe.
35 . (canceled)
36 . The method of claim 34 , wherein said target specific nucleic acid probe comprises four or more genedigits.
37 . The method of claim 34 , wherein said target specific nucleic acid probe comprise five or more genedigits.
38 .- 40 . (canceled)
41 . The method of claim 34 , wherein at least one of said anti-genedigits hybridizes to its corresponding genedigit through a sequence having a complexity less than the number of hybridized base pairs.
42 . The method of claim 41 , wherein said number of hybridized base pairs is about 24.
43 .- 44 . (canceled)
45 . The method of claim 34 , wherein said anti-genedigits comprise a label monomer or combination of label monomers.
46 . The method of claim 45 , wherein each of said different anti-genedigits comprises a unique label monomer or combination of label monomers.
47 .- 48 . (canceled)
49 . A method of producing a population of uniquely labeled nucleic acid probes, comprising: (a) synthesizing a population of target specific nucleic acid probes each having a different specifier; (b) synthesizing a corresponding population of anti-genedigits each having a unique label monomer or combination of label monomers, said population having a diversity sufficient to uniquely hybridize to genedigits within said specifiers, and (c) hybridizing said populations of target nucleic acid probes to said anti-genedigits, to produce a population wherein each of said target specific probes is uniquely labeled.
50 .- 84 . (canceled)
85 . The method of claim 45 , wherein said label monomers are selected from radioisotopes, fluorochromes, dyes, enzymes, nanoparticles, chemiluminescent markers, and biotin.
86 . The method of claim 45 , wherein each of said target specific nucleic acid probes comprises a mixture of two or more different label monomers.
87 . The method of claim 45 , wherein at least one label monomer is a quantum dot.
88 . The method of claim 45 , wherein at least one anti-genedigit is a dendrimer.
89 . The method of claim 45 , wherein each said anti-genedigit is covalently attached to each said at least one label monomer.Join the waitlist — get patent alerts
Track US2009220978A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.